Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis

BACKGROUND: In patients with heart failure (HF), randomized controlled trials (RCTs) of sodium-glucose transporter-2 inhibitors (SGLT-2is) have proven to be effective in decreasing the primary composite outcome of cardiovascular death and hospitalizations for HF. A recently published meta-analysis s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Frederick Berro, Tang, Vincent Anthony S., De Luna, Deogracias Villa, Lerma, Edgar V., Vijayaraghavan, Krishnaswami, Kazory, Amir, Shah, Nilay S., Volgman, Annabelle Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256233/
https://www.ncbi.nlm.nih.gov/pubmed/37305172
http://dx.doi.org/10.1016/j.ahjo.2023.100261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256233/
https://www.ncbi.nlm.nih.gov/pubmed/37305172
http://dx.doi.org/10.1016/j.ahjo.2023.100261

Ejemplares similares